India Meropenem Market By Product Type (Meropenem Sodium v/s Meropenem Trihydrate), By Source (In-house v/s Contract Manufacturing Organizations), By Dose (500 mg/vial v/s 1gm/vial), By Distribution Channel (Online v/s Offline), By Application (Skin and Skin Structure Infection, Intra-abdominal infection, Meningitis, Nosocomial Infection and Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026

India meropenem market is expected to grow at a steady rate during the forecast period. The India meropenem market is driven by high use of this medication to treat a number of bacterial infections. Additionally, the drug is also used to treat hospital acquired pneumonia which is further expected to boost the demand through FY2026. Improvement in healthcare infrastructure is further predicted to bolster the market growth in the years to come.

The India meropenem market is segmented based on product type, source, dose, distribution channel, application, end user, company, and region. Based on application, the market can be segmented into skin and skin structure infection, intra-abdominal infection, meningitis, nosocomial infection and others. Among these, skin and skin structure infection segment is expected to witness high growth in the market over the coming years on account of increasing prevalence of complicated skin infections amongst the population in the country. Also, the effectiveness of the drug in treating skin infections is further bolstering the market growth in the coming years.

The major players operating in the India meropenem market are Blue Cross Laboratories Ltd, Coral Pharmaceuticals (P) Ltd., Lincoln Pharmaceuticals Ltd., Intra Labs India Pvt. Ltd., United Biotech Pvt. Ltd., Cipla Ltd., Taj Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Baxter India Pvt. Ltd., AstraZeneca Pharma India Ltd. and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies, and launching new products to stay competitive in the market. Other inorganic growth strategies include mergers and acquisitions, joint ventures and new product developments in order to sustain themselves amidst fierce competition.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022-FY2026

Objective of the Study:

• To analyze historical growth of the market size of India meropenem market from FY2016 to FY2019.
• To estimate and forecast the market size of India meropenem market from FY2020 to FY2026 and growth rate until FY2026.
• To classify and forecast India meropenem market based on product type, source, dose, distribution channel, application, end user, company, and regional distribution.
• To identify dominant region or segment in the India meropenem market.
• To identify drivers and challenges for India meropenem market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India meropenem market.
• To identify and analyze the profiles of leading players operating in India meropenem market.
• To identify key sustainable strategies adopted by market players in India meropenem market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India meropenem market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated them through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

• Meropenem manufacturers/ suppliers/ distributors
• Market research and consulting firms
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to meropenem

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India meropenem market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• India Meropenem Market, By Product Type:
• Meropenem Sodium
• Meropenem Trihydrate
• India Meropenem Market, By Source:
• In-house
• Contract Manufacturing Organizations
• India Meropenem Market, By Dose:
• 500 mg/vial
• 1gm/vial
• India Meropenem Market, By Distribution Channel:
• Online
• Offline
• India Meropenem Market, By Application:
• Skin and Skin Structure Infection
• Intra-abdominal infection
• Meningitis
• Nosocomial Infection
• Others
• India Meropenem Market, By End User:
• Adult
• Pediatric
• India Meropenem Market, By Region:
• North
• South
• East
• West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India meropenem market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

India meropenem market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected] 

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Meropenem Market

4.    Executive Summary

5.    Manufacturing Meropenem

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Meropenem

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Meropenem Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Product Type (Meropenem Sodium v/s Meropenem Trihydrate)

7.2.2.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.3.     By Dose (500 mg/vial v/s 1gm/vial)

7.2.4.     By Distribution Channel (Online v/s Offline)

7.2.5.     By Application (Skin and Skin Structure Infection, Intra-abdominal infection, Meningitis, Nosocomial Infection and Others)

7.2.6.     By End User (Adult v/s Pediatric)

7.2.7.     By Region (North, East, South, West)

7.2.8.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers

8.2.  Challenges

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Blue Cross Laboratories Ltd.

14.1.1.1.      Company Brief

14.1.1.2.      Production Plants & Capacity (If Available)

14.1.1.3.      Financials (If Available)

14.1.1.4.      Captive Consumption Vs Merchant Sale

14.1.1.5.      Current & Future Plans

14.1.2.  Coral Pharmaceuticals (P) Ltd.

14.1.3.  Lincoln Pharmaceuticals Ltd.

14.1.4.  Intra Labs India Pvt. Ltd.

14.1.5.  United Biotech Pvt. Ltd.

14.1.6.  Cipla Ltd.

14.1.7.  Taj Pharmaceuticals Ltd.

14.1.8.  Macleods Pharmaceuticals Ltd.

14.1.9.  Baxter India Pvt. Ltd.

14.1.10. AstraZeneca Pharma India Ltd.

15.  Strategic Recommendations

16. About Us & Disclaimer